A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as vinblastine, cyclophosphamide, procarbazine,
prednisolone, etoposide, mitoxantrone, and bleomycin, work in different ways to stop cancer
cells from dividing so they stop growing or die. Combining more than one chemotherapy drug
may kill more cancer cells.
PURPOSE: This phase II trial is studying how well combination chemotherapy works in treating
older patients with previously untreated Hodgkin's lymphoma.